AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 98 filers reported holding AERIE PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $621,000 | -87.2% | 16,400 | -87.2% | 0.41% | -75.2% |
| Q3 2016 | $4,846,000 | +1242.4% | 128,400 | +526.3% | 1.65% | +1047.2% |
| Q2 2016 | $361,000 | +45.0% | 20,500 | 0.0% | 0.14% | +39.8% |
| Q1 2016 | $249,000 | -50.1% | 20,500 | 0.0% | 0.10% | -26.4% |
| Q4 2015 | $499,000 | +37.1% | 20,500 | 0.0% | 0.14% | +100.0% |
| Q3 2015 | $364,000 | -91.5% | 20,500 | -91.6% | 0.07% | -82.8% |
| Q2 2015 | $4,307,000 | -45.8% | 244,000 | -3.8% | 0.41% | -45.9% |
| Q1 2015 | $7,951,000 | +3.8% | 253,700 | -3.3% | 0.75% | +2.3% |
| Q4 2014 | $7,659,000 | +38.8% | 262,400 | -1.6% | 0.73% | +28.8% |
| Q3 2014 | $5,520,000 | -26.0% | 266,800 | -11.4% | 0.57% | -11.1% |
| Q2 2014 | $7,461,000 | +17.7% | 301,200 | +0.7% | 0.64% | +23.7% |
| Q1 2014 | $6,338,000 | +13.6% | 299,100 | -3.7% | 0.52% | +13.3% |
| Q4 2013 | $5,577,000 | – | 310,500 | – | 0.46% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 805,217 | $14,212,000 | 4.99% |
| DAFNA Capital Management LLC | 156,842 | $2,768,000 | 2.34% |
| NORTHPOINTE CAPITAL LLC | 1,034,400 | $18,257,000 | 2.15% |
| HARVEY CAPITAL MANAGEMENT INC | 223,200 | $3,856,000 | 1.30% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,211,644 | $39,036,000 | 1.30% |
| Boulegeris Investments, Inc. | 88,660 | $1,565,000 | 1.12% |
| Partner Investment Management, L.P. | 43,623 | $770,000 | 1.08% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 150,000 | $2,648,000 | 0.92% |
| PFM Health Sciences, LP | 1,851,564 | $32,680,000 | 0.83% |
| Benchmark Capital Advisors | 55,400 | $978,000 | 0.69% |